Share Price and Basic Stock Data
Last Updated: November 8, 2025, 2:37 am
| PEG Ratio | 0.51 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Himadri Speciality Chemical Ltd operates in the chemicals sector, specifically focusing on specialty chemicals. As of the latest reporting period, the company’s stock price stood at ₹474, with a market capitalization of ₹23,453 Cr. The company has showcased significant revenue growth over the years, with total sales reported at ₹4,172 Cr for FY 2023, reflecting a substantial increase from ₹2,791 Cr in FY 2022. The trailing twelve months (TTM) revenue is reported at ₹4,531 Cr, indicating a robust upward trajectory. Quarterly sales figures have also shown resilience; for instance, the sales for Q1 FY 2025 reached ₹1,177 Cr, up from ₹1,029 Cr in Q4 FY 2024. This growth trend is supported by a diversified product portfolio and increasing market demand, positioning Himadri as a competitive player in the specialty chemicals market.
Profitability and Efficiency Metrics
Himadri Speciality Chemical Ltd has demonstrated solid profitability metrics, with a net profit of ₹612 Cr for the most recent fiscal year, significantly higher than the previous year’s ₹216 Cr. The company reported an operating profit margin (OPM) of 22% for FY 2025, showcasing an improvement from 10% in FY 2023. The return on equity (ROE) stood at 16.4%, while return on capital employed (ROCE) was reported at an impressive 22%. The interest coverage ratio (ICR) reached 20.23 times, indicating strong capability to cover interest expenses, which is significantly higher than many industry peers. These metrics reflect effective cost management and operational efficiency, positioning Himadri favorably within the specialty chemicals sector.
Balance Sheet Strength and Financial Ratios
The balance sheet of Himadri Speciality Chemical Ltd reveals a robust financial position. Total borrowings as of FY 2025 were reported at ₹313 Cr, a notable decrease from ₹842 Cr in FY 2023, indicating improved debt management. Reserves have seen consistent growth, rising to ₹3,672 Cr in FY 2025 from ₹2,237 Cr in FY 2023, signaling enhanced retained earnings and financial stability. The company has a current ratio of 3.56, suggesting strong liquidity, while the debt-to-equity ratio stood at 0.08, indicating low financial leverage. Additionally, the price-to-book value (P/BV) ratio is reported at 5.62x, suggesting that the market values the company significantly higher than its book value, reflecting investor confidence in its growth prospects.
Shareholding Pattern and Investor Confidence
Himadri’s shareholding structure indicates a balanced mix of ownership. Promoters hold a significant 51.60% stake, reflecting strong control and commitment to the company’s long-term vision. Foreign institutional investors (FIIs) have increased their participation to 5.20%, while domestic institutional investors (DIIs) hold 4.83%. The public shareholding stands at 38.36%, showcasing a broad base of retail investors. The total number of shareholders has also risen to 4,48,339, indicating growing interest and confidence among retail investors. The increasing FII and DII holdings suggest a positive outlook from institutional investors, which can enhance the company’s market credibility and support its growth initiatives.
Outlook, Risks, and Final Insight
Looking ahead, Himadri Speciality Chemical Ltd faces both opportunities and challenges. The company is well-positioned in the growing specialty chemicals market, supported by its solid financial metrics and increasing demand for its products. However, risks such as fluctuations in raw material prices and potential regulatory changes could impact profitability. Additionally, the company’s reliance on a few key markets may pose risks if market dynamics shift. Strengths include its strong operational efficiency and low debt levels, while risks involve market volatility and competitive pressures. Overall, with the current growth trajectory and strategic focus, Himadri is poised for further expansion, provided it navigates these risks effectively.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Himadri Speciality Chemical Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 451 Cr. | 49.1 | 86.7/42.6 | 27.5 | 20.0 | 0.81 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 37.6 Cr. | 76.6 | 103/56.0 | 16.8 | 87.4 | 1.30 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 45.1 Cr. | 663 | 1,140/0.00 | 20.8 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,658 Cr. | 80.7 | 111/78.0 | 24.2 | 22.0 | 0.62 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 730 Cr. | 293 | 453/241 | 26.2 | 91.1 | 0.85 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,641.60 Cr | 720.76 | 46.28 | 180.65 | 0.41% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,047 | 1,059 | 1,037 | 1,029 | 951 | 1,005 | 1,053 | 1,177 | 1,200 | 1,137 | 1,141 | 1,135 | 1,118 |
| Expenses | 975 | 962 | 932 | 903 | 817 | 847 | 879 | 997 | 1,008 | 929 | 920 | 901 | 873 |
| Operating Profit | 72 | 97 | 105 | 126 | 134 | 158 | 174 | 180 | 192 | 208 | 221 | 233 | 245 |
| OPM % | 7% | 9% | 10% | 12% | 14% | 16% | 17% | 15% | 16% | 18% | 19% | 21% | 22% |
| Other Income | 2 | -22 | 8 | 11 | 10 | 10 | 10 | 12 | 13 | 14 | 12 | 14 | 27 |
| Interest | 13 | 20 | 20 | 13 | 13 | 16 | 21 | 14 | 13 | 11 | 12 | 9 | 16 |
| Depreciation | 13 | 13 | 13 | 12 | 12 | 12 | 13 | 13 | 13 | 13 | 15 | 14 | 15 |
| Profit before tax | 48 | 42 | 79 | 111 | 119 | 139 | 150 | 166 | 179 | 197 | 206 | 224 | 241 |
| Tax % | 20% | 15% | 18% | 31% | 28% | 28% | 28% | 30% | 31% | 31% | 31% | 31% | 26% |
| Net Profit | 39 | 36 | 65 | 76 | 86 | 101 | 109 | 115 | 123 | 136 | 141 | 155 | 179 |
| EPS in Rs | 0.92 | 0.86 | 1.55 | 1.76 | 1.96 | 2.29 | 2.47 | 2.34 | 2.48 | 2.74 | 2.88 | 3.15 | 3.68 |
Last Updated: August 1, 2025, 8:05 pm
Below is a detailed analysis of the quarterly data for Himadri Speciality Chemical Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 1,118.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,135.00 Cr. (Mar 2025) to 1,118.00 Cr., marking a decrease of 17.00 Cr..
- For Expenses, as of Jun 2025, the value is 873.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 901.00 Cr. (Mar 2025) to 873.00 Cr., marking a decrease of 28.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 245.00 Cr.. The value appears strong and on an upward trend. It has increased from 233.00 Cr. (Mar 2025) to 245.00 Cr., marking an increase of 12.00 Cr..
- For OPM %, as of Jun 2025, the value is 22.00%. The value appears strong and on an upward trend. It has increased from 21.00% (Mar 2025) to 22.00%, marking an increase of 1.00%.
- For Other Income, as of Jun 2025, the value is 27.00 Cr.. The value appears strong and on an upward trend. It has increased from 14.00 Cr. (Mar 2025) to 27.00 Cr., marking an increase of 13.00 Cr..
- For Interest, as of Jun 2025, the value is 16.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9.00 Cr. (Mar 2025) to 16.00 Cr., marking an increase of 7.00 Cr..
- For Depreciation, as of Jun 2025, the value is 15.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14.00 Cr. (Mar 2025) to 15.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 241.00 Cr.. The value appears strong and on an upward trend. It has increased from 224.00 Cr. (Mar 2025) to 241.00 Cr., marking an increase of 17.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be improving (decreasing) as expected. It has decreased from 31.00% (Mar 2025) to 26.00%, marking a decrease of 5.00%.
- For Net Profit, as of Jun 2025, the value is 179.00 Cr.. The value appears strong and on an upward trend. It has increased from 155.00 Cr. (Mar 2025) to 179.00 Cr., marking an increase of 24.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 3.68. The value appears strong and on an upward trend. It has increased from 3.15 (Mar 2025) to 3.68, marking an increase of 0.53.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: July 22, 2025, 3:42 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,395 | 1,437 | 1,182 | 1,341 | 2,022 | 2,422 | 1,806 | 1,679 | 2,791 | 4,172 | 4,185 | 4,613 | 4,531 |
| Expenses | 1,307 | 1,313 | 1,036 | 1,107 | 1,569 | 1,863 | 1,525 | 1,549 | 2,635 | 3,773 | 3,540 | 3,758 | 3,623 |
| Operating Profit | 88 | 124 | 146 | 233 | 452 | 560 | 280 | 131 | 156 | 399 | 645 | 854 | 907 |
| OPM % | 6% | 9% | 12% | 17% | 22% | 23% | 16% | 8% | 6% | 10% | 15% | 19% | 20% |
| Other Income | 13 | 13 | 9 | 6 | 12 | 8 | 8 | 14 | -17 | -2 | 43 | 52 | 66 |
| Interest | 118 | 103 | 111 | 82 | 70 | 71 | 55 | 33 | 36 | 66 | 64 | 45 | 48 |
| Depreciation | 58 | 59 | 67 | 33 | 33 | 34 | 39 | 47 | 50 | 51 | 50 | 55 | 57 |
| Profit before tax | -75 | -24 | -23 | 125 | 361 | 462 | 194 | 65 | 53 | 280 | 574 | 806 | 869 |
| Tax % | -22% | -49% | -19% | 34% | 31% | 30% | -6% | 27% | 27% | 23% | 28% | 31% | |
| Net Profit | -58 | -13 | -19 | 82 | 248 | 324 | 205 | 47 | 39 | 216 | 411 | 555 | 612 |
| EPS in Rs | -1.48 | -0.32 | -0.44 | 1.98 | 5.91 | 7.75 | 4.91 | 1.13 | 0.98 | 4.99 | 8.34 | 11.25 | 12.45 |
| Dividend Payout % | -7% | 0% | -11% | 5% | 2% | 2% | 3% | 13% | 20% | 5% | 6% | 5% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 77.59% | -46.15% | 531.58% | 202.44% | 30.65% | -36.73% | -77.07% | -17.02% | 453.85% | 90.28% | 35.04% |
| Change in YoY Net Profit Growth (%) | 0.00% | -123.74% | 577.73% | -329.14% | -171.79% | -67.37% | -40.34% | 60.05% | 470.87% | -363.57% | -55.24% |
Himadri Speciality Chemical Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 21% |
| 3 Years: | 18% |
| TTM: | 2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 40% |
| 5 Years: | 22% |
| 3 Years: | 111% |
| TTM: | 37% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 41% |
| 5 Years: | 53% |
| 3 Years: | 65% |
| 1 Year: | -15% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 11% |
| 3 Years: | 15% |
| Last Year: | 16% |
Last Updated: September 5, 2025, 6:10 am
Balance Sheet
Last Updated: June 16, 2025, 12:01 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 39 | 39 | 42 | 42 | 42 | 42 | 42 | 42 | 42 | 43 | 49 | 49 |
| Reserves | 757 | 750 | 837 | 988 | 1,373 | 1,590 | 1,692 | 1,751 | 1,826 | 2,237 | 2,996 | 3,672 |
| Borrowings | 1,362 | 1,124 | 887 | 774 | 660 | 476 | 505 | 729 | 587 | 842 | 605 | 313 |
| Other Liabilities | 339 | 329 | 296 | 308 | 341 | 680 | 323 | 269 | 999 | 555 | 798 | 621 |
| Total Liabilities | 2,497 | 2,242 | 2,062 | 2,112 | 2,416 | 2,788 | 2,562 | 2,791 | 3,454 | 3,678 | 4,449 | 4,656 |
| Fixed Assets | 1,221 | 1,228 | 1,180 | 1,174 | 1,178 | 1,170 | 1,475 | 1,468 | 1,546 | 1,515 | 1,534 | 1,605 |
| CWIP | 59 | 14 | 31 | 13 | 22 | 133 | 158 | 160 | 77 | 94 | 67 | 185 |
| Investments | 168 | 23 | 53 | 87 | 273 | 179 | 47 | 66 | 113 | 132 | 478 | 582 |
| Other Assets | 1,048 | 977 | 798 | 838 | 943 | 1,305 | 882 | 1,098 | 1,718 | 1,938 | 2,371 | 2,283 |
| Total Assets | 2,497 | 2,242 | 2,062 | 2,112 | 2,416 | 2,788 | 2,562 | 2,791 | 3,454 | 3,678 | 4,449 | 4,656 |
Below is a detailed analysis of the balance sheet data for Himadri Speciality Chemical Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 49.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 49.00 Cr..
- For Reserves, as of Mar 2025, the value is 3,672.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,996.00 Cr. (Mar 2024) to 3,672.00 Cr., marking an increase of 676.00 Cr..
- For Borrowings, as of Mar 2025, the value is 313.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 605.00 Cr. (Mar 2024) to 313.00 Cr., marking a decrease of 292.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 621.00 Cr.. The value appears to be improving (decreasing). It has decreased from 798.00 Cr. (Mar 2024) to 621.00 Cr., marking a decrease of 177.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 4,656.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,449.00 Cr. (Mar 2024) to 4,656.00 Cr., marking an increase of 207.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 1,605.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,534.00 Cr. (Mar 2024) to 1,605.00 Cr., marking an increase of 71.00 Cr..
- For CWIP, as of Mar 2025, the value is 185.00 Cr.. The value appears strong and on an upward trend. It has increased from 67.00 Cr. (Mar 2024) to 185.00 Cr., marking an increase of 118.00 Cr..
- For Investments, as of Mar 2025, the value is 582.00 Cr.. The value appears strong and on an upward trend. It has increased from 478.00 Cr. (Mar 2024) to 582.00 Cr., marking an increase of 104.00 Cr..
- For Other Assets, as of Mar 2025, the value is 2,283.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,371.00 Cr. (Mar 2024) to 2,283.00 Cr., marking a decrease of 88.00 Cr..
- For Total Assets, as of Mar 2025, the value is 4,656.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,449.00 Cr. (Mar 2024) to 4,656.00 Cr., marking an increase of 207.00 Cr..
Notably, the Reserves (3,672.00 Cr.) exceed the Borrowings (313.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 87.00 | 123.00 | -741.00 | -541.00 | -208.00 | 84.00 | -225.00 | -598.00 | -431.00 | -443.00 | 40.00 | 541.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 92 | 82 | 63 | 60 | 49 | 55 | 61 | 100 | 66 | 44 | 57 | 50 |
| Inventory Days | 134 | 122 | 138 | 164 | 112 | 124 | 121 | 100 | 125 | 61 | 85 | 68 |
| Days Payable | 36 | 36 | 50 | 74 | 39 | 100 | 68 | 45 | 127 | 39 | 69 | 28 |
| Cash Conversion Cycle | 191 | 168 | 151 | 150 | 122 | 79 | 113 | 155 | 65 | 66 | 73 | 90 |
| Working Capital Days | -11 | 4 | -22 | 19 | 29 | 40 | 10 | 15 | -1 | 1 | 32 | 69 |
| ROCE % | 2% | 3% | 5% | 11% | 22% | 25% | 11% | 4% | 5% | 13% | 19% | 22% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Motilal Oswal Nifty Microcap 250 Index Fund | 230,983 | 1.2 | 5.51 | 230,983 | 2025-04-22 17:25:32 | 0% |
| Groww Nifty Total Market Index Fund | 539 | 0.04 | 0.01 | 539 | 2025-04-22 17:25:32 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 11.26 | 9.16 | 5.13 | 0.98 | 1.13 |
| Diluted EPS (Rs.) | 11.17 | 9.16 | 5.13 | 0.98 | 1.13 |
| Cash EPS (Rs.) | 12.35 | 9.35 | 6.16 | 2.11 | 2.25 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 75.37 | 61.77 | 52.64 | 44.51 | 42.78 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 75.37 | 61.77 | 52.64 | 44.51 | 42.78 |
| Revenue From Operations / Share (Rs.) | 93.41 | 84.96 | 96.41 | 66.62 | 40.09 |
| PBDIT / Share (Rs.) | 18.35 | 13.96 | 9.87 | 3.90 | 3.46 |
| PBIT / Share (Rs.) | 17.23 | 12.95 | 8.70 | 2.71 | 2.34 |
| PBT / Share (Rs.) | 16.33 | 11.65 | 6.48 | 1.28 | 1.54 |
| Net Profit / Share (Rs.) | 11.24 | 8.34 | 4.99 | 0.93 | 1.13 |
| NP After MI And SOA / Share (Rs.) | 11.25 | 8.34 | 4.99 | 0.97 | 1.13 |
| PBDIT Margin (%) | 19.63 | 16.43 | 10.23 | 5.84 | 8.63 |
| PBIT Margin (%) | 18.44 | 15.23 | 9.02 | 4.07 | 5.83 |
| PBT Margin (%) | 17.47 | 13.71 | 6.71 | 1.91 | 3.84 |
| Net Profit Margin (%) | 12.03 | 9.81 | 5.17 | 1.39 | 2.81 |
| NP After MI And SOA Margin (%) | 12.04 | 9.81 | 5.17 | 1.46 | 2.82 |
| Return on Networth / Equity (%) | 14.92 | 13.48 | 9.47 | 2.19 | 2.64 |
| Return on Capital Employeed (%) | 21.00 | 19.64 | 15.48 | 5.57 | 5.02 |
| Return On Assets (%) | 11.93 | 9.23 | 5.87 | 1.18 | 1.70 |
| Long Term Debt / Equity (X) | 0.00 | 0.01 | 0.02 | 0.04 | 0.04 |
| Total Debt / Equity (X) | 0.08 | 0.19 | 0.36 | 0.30 | 0.37 |
| Asset Turnover Ratio (%) | 1.01 | 1.03 | 1.17 | 0.90 | 0.63 |
| Current Ratio (X) | 3.56 | 1.92 | 1.51 | 1.18 | 1.25 |
| Quick Ratio (X) | 2.59 | 1.33 | 1.07 | 0.63 | 0.84 |
| Inventory Turnover Ratio (X) | 4.90 | 4.92 | 4.99 | 4.30 | 3.13 |
| Dividend Payout Ratio (NP) (%) | 4.44 | 2.63 | 3.88 | 15.34 | 13.23 |
| Dividend Payout Ratio (CP) (%) | 4.04 | 2.34 | 3.14 | 6.94 | 6.65 |
| Earning Retention Ratio (%) | 95.56 | 97.37 | 96.12 | 84.66 | 86.77 |
| Cash Earning Retention Ratio (%) | 95.96 | 97.66 | 96.86 | 93.06 | 93.35 |
| Interest Coverage Ratio (X) | 20.23 | 10.77 | 6.47 | 4.58 | 4.34 |
| Interest Coverage Ratio (Post Tax) (X) | 13.40 | 7.43 | 4.72 | 2.79 | 2.41 |
| Enterprise Value (Cr.) | 20619.97 | 14725.34 | 3988.71 | 3425.68 | 2287.01 |
| EV / Net Operating Revenue (X) | 4.47 | 3.52 | 0.95 | 1.23 | 1.36 |
| EV / EBITDA (X) | 22.76 | 21.42 | 9.34 | 20.98 | 15.78 |
| MarketCap / Net Operating Revenue (X) | 4.54 | 3.55 | 0.90 | 1.12 | 1.04 |
| Retention Ratios (%) | 95.55 | 97.36 | 96.11 | 84.65 | 86.76 |
| Price / BV (X) | 5.62 | 4.88 | 1.66 | 1.67 | 0.97 |
| Price / Net Operating Revenue (X) | 4.54 | 3.55 | 0.90 | 1.12 | 1.04 |
| EarningsYield | 0.02 | 0.02 | 0.05 | 0.01 | 0.02 |
After reviewing the key financial ratios for Himadri Speciality Chemical Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 11.26. This value is within the healthy range. It has increased from 9.16 (Mar 24) to 11.26, marking an increase of 2.10.
- For Diluted EPS (Rs.), as of Mar 25, the value is 11.17. This value is within the healthy range. It has increased from 9.16 (Mar 24) to 11.17, marking an increase of 2.01.
- For Cash EPS (Rs.), as of Mar 25, the value is 12.35. This value is within the healthy range. It has increased from 9.35 (Mar 24) to 12.35, marking an increase of 3.00.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 75.37. It has increased from 61.77 (Mar 24) to 75.37, marking an increase of 13.60.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 75.37. It has increased from 61.77 (Mar 24) to 75.37, marking an increase of 13.60.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 93.41. It has increased from 84.96 (Mar 24) to 93.41, marking an increase of 8.45.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 18.35. This value is within the healthy range. It has increased from 13.96 (Mar 24) to 18.35, marking an increase of 4.39.
- For PBIT / Share (Rs.), as of Mar 25, the value is 17.23. This value is within the healthy range. It has increased from 12.95 (Mar 24) to 17.23, marking an increase of 4.28.
- For PBT / Share (Rs.), as of Mar 25, the value is 16.33. This value is within the healthy range. It has increased from 11.65 (Mar 24) to 16.33, marking an increase of 4.68.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 11.24. This value is within the healthy range. It has increased from 8.34 (Mar 24) to 11.24, marking an increase of 2.90.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 11.25. This value is within the healthy range. It has increased from 8.34 (Mar 24) to 11.25, marking an increase of 2.91.
- For PBDIT Margin (%), as of Mar 25, the value is 19.63. This value is within the healthy range. It has increased from 16.43 (Mar 24) to 19.63, marking an increase of 3.20.
- For PBIT Margin (%), as of Mar 25, the value is 18.44. This value is within the healthy range. It has increased from 15.23 (Mar 24) to 18.44, marking an increase of 3.21.
- For PBT Margin (%), as of Mar 25, the value is 17.47. This value is within the healthy range. It has increased from 13.71 (Mar 24) to 17.47, marking an increase of 3.76.
- For Net Profit Margin (%), as of Mar 25, the value is 12.03. This value exceeds the healthy maximum of 10. It has increased from 9.81 (Mar 24) to 12.03, marking an increase of 2.22.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 12.04. This value is within the healthy range. It has increased from 9.81 (Mar 24) to 12.04, marking an increase of 2.23.
- For Return on Networth / Equity (%), as of Mar 25, the value is 14.92. This value is below the healthy minimum of 15. It has increased from 13.48 (Mar 24) to 14.92, marking an increase of 1.44.
- For Return on Capital Employeed (%), as of Mar 25, the value is 21.00. This value is within the healthy range. It has increased from 19.64 (Mar 24) to 21.00, marking an increase of 1.36.
- For Return On Assets (%), as of Mar 25, the value is 11.93. This value is within the healthy range. It has increased from 9.23 (Mar 24) to 11.93, marking an increase of 2.70.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.08. This value is within the healthy range. It has decreased from 0.19 (Mar 24) to 0.08, marking a decrease of 0.11.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.01. It has decreased from 1.03 (Mar 24) to 1.01, marking a decrease of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 3.56. This value exceeds the healthy maximum of 3. It has increased from 1.92 (Mar 24) to 3.56, marking an increase of 1.64.
- For Quick Ratio (X), as of Mar 25, the value is 2.59. This value exceeds the healthy maximum of 2. It has increased from 1.33 (Mar 24) to 2.59, marking an increase of 1.26.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.90. This value is within the healthy range. It has decreased from 4.92 (Mar 24) to 4.90, marking a decrease of 0.02.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 4.44. This value is below the healthy minimum of 20. It has increased from 2.63 (Mar 24) to 4.44, marking an increase of 1.81.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 4.04. This value is below the healthy minimum of 20. It has increased from 2.34 (Mar 24) to 4.04, marking an increase of 1.70.
- For Earning Retention Ratio (%), as of Mar 25, the value is 95.56. This value exceeds the healthy maximum of 70. It has decreased from 97.37 (Mar 24) to 95.56, marking a decrease of 1.81.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 95.96. This value exceeds the healthy maximum of 70. It has decreased from 97.66 (Mar 24) to 95.96, marking a decrease of 1.70.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 20.23. This value is within the healthy range. It has increased from 10.77 (Mar 24) to 20.23, marking an increase of 9.46.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 13.40. This value is within the healthy range. It has increased from 7.43 (Mar 24) to 13.40, marking an increase of 5.97.
- For Enterprise Value (Cr.), as of Mar 25, the value is 20,619.97. It has increased from 14,725.34 (Mar 24) to 20,619.97, marking an increase of 5,894.63.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.47. This value exceeds the healthy maximum of 3. It has increased from 3.52 (Mar 24) to 4.47, marking an increase of 0.95.
- For EV / EBITDA (X), as of Mar 25, the value is 22.76. This value exceeds the healthy maximum of 15. It has increased from 21.42 (Mar 24) to 22.76, marking an increase of 1.34.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.54. This value exceeds the healthy maximum of 3. It has increased from 3.55 (Mar 24) to 4.54, marking an increase of 0.99.
- For Retention Ratios (%), as of Mar 25, the value is 95.55. This value exceeds the healthy maximum of 70. It has decreased from 97.36 (Mar 24) to 95.55, marking a decrease of 1.81.
- For Price / BV (X), as of Mar 25, the value is 5.62. This value exceeds the healthy maximum of 3. It has increased from 4.88 (Mar 24) to 5.62, marking an increase of 0.74.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.54. This value exceeds the healthy maximum of 3. It has increased from 3.55 (Mar 24) to 4.54, marking an increase of 0.99.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Himadri Speciality Chemical Ltd:
- Net Profit Margin: 12.03%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 21% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 14.92% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 13.4
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.59
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 34.1 (Industry average Stock P/E: 46.28)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.08
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 12.03%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Carbon Black | Fortuna Tower, 23-A, Netaji Subhas Road, Kolkata West Bengal 700001 | info@himadri.com http://www.himadri.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Anurag Choudhary | Chairman & M.D & CEO |
| Mr. Shyam Sundar Choudhary | Executive Director |
| Mr. Amit Choudhary | Executive Director |
| Mr. Girish Paman Vanvari | Independent Director |
| Mr. Gopal Ajay Malpani | Independent Director |
| Ms. Rita Bhattacharya | Independent Director |
| Mr. Amitabh Srivastava | Independent Director |
FAQ
What is the intrinsic value of Himadri Speciality Chemical Ltd?
Himadri Speciality Chemical Ltd's intrinsic value (as of 09 November 2025) is 368.68 which is 18.61% lower the current market price of 453.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 22,385 Cr. market cap, FY2025-2026 high/low of 607/351, reserves of ₹3,672 Cr, and liabilities of 4,656 Cr.
What is the Market Cap of Himadri Speciality Chemical Ltd?
The Market Cap of Himadri Speciality Chemical Ltd is 22,385 Cr..
What is the current Stock Price of Himadri Speciality Chemical Ltd as on 09 November 2025?
The current stock price of Himadri Speciality Chemical Ltd as on 09 November 2025 is 453.
What is the High / Low of Himadri Speciality Chemical Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Himadri Speciality Chemical Ltd stocks is 607/351.
What is the Stock P/E of Himadri Speciality Chemical Ltd?
The Stock P/E of Himadri Speciality Chemical Ltd is 34.1.
What is the Book Value of Himadri Speciality Chemical Ltd?
The Book Value of Himadri Speciality Chemical Ltd is 82.3.
What is the Dividend Yield of Himadri Speciality Chemical Ltd?
The Dividend Yield of Himadri Speciality Chemical Ltd is 0.13 %.
What is the ROCE of Himadri Speciality Chemical Ltd?
The ROCE of Himadri Speciality Chemical Ltd is 22.0 %.
What is the ROE of Himadri Speciality Chemical Ltd?
The ROE of Himadri Speciality Chemical Ltd is 16.4 %.
What is the Face Value of Himadri Speciality Chemical Ltd?
The Face Value of Himadri Speciality Chemical Ltd is 1.00.